ID   S27A1_HUMAN             Reviewed;         646 AA.
AC   Q6PCB7; A6NIH2; B7Z662;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   07-APR-2021, entry version 155.
DE   RecName: Full=Long-chain fatty acid transport protein 1 {ECO:0000305};
DE            Short=FATP-1 {ECO:0000303|PubMed:10873384};
DE            Short=Fatty acid transport protein 1 {ECO:0000303|PubMed:10873384};
DE            EC=6.2.1.15 {ECO:0000250|UniProtKB:Q60714};
DE   AltName: Full=Solute carrier family 27 member 1 {ECO:0000312|HGNC:HGNC:10995};
GN   Name=SLC27A1 {ECO:0000312|HGNC:HGNC:10995}; Synonyms=ACSVL5, FATP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=10873384; DOI=10.1006/geno.2000.6191;
RA   Martin G., Nemoto M., Gelman L., Geffroy S., Najib J., Fruchart J.-C.,
RA   Roevens P., de Martinville B., Deeb S., Auwerx J.;
RT   "The human fatty acid transport protein-1 (SLC27A1; FATP-1) cDNA and gene:
RT   organization, chromosomal localization, and expression.";
RL   Genomics 66:296-304(2000).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12556534; DOI=10.1074/jbc.m211412200;
RA   Gimeno R.E., Ortegon A.M., Patel S., Punreddy S., Ge P., Sun Y.,
RA   Lodish H.F., Stahl A.;
RT   "Characterization of a heart-specific fatty acid transport protein.";
RL   J. Biol. Chem. 278:16039-16044(2003).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20530735; DOI=10.1152/ajpendo.00226.2010;
RA   Falcon A., Doege H., Fluitt A., Tsang B., Watson N., Kay M.A., Stahl A.;
RT   "FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain
RT   acyl-CoA synthetase.";
RL   Am. J. Physiol. 299:E384-393(2010).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=21395585; DOI=10.1111/j.1471-4159.2011.07245.x;
RA   Mitchell R.W., On N.H., Del Bigio M.R., Miller D.W., Hatch G.M.;
RT   "Fatty acid transport protein expression in human brain and potential role
RT   in fatty acid transport across human brain microvessel endothelial cells.";
RL   J. Neurochem. 117:735-746(2011).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH EPRS1.
RX   PubMed=28178239; DOI=10.1038/nature21380;
RA   Arif A., Terenzi F., Potdar A.A., Jia J., Sacks J., China A., Halawani D.,
RA   Vasu K., Li X., Brown J.M., Chen J., Kozma S.C., Thomas G., Fox P.L.;
RT   "EPRS is a critical mTORC1-S6K1 effector that influences adiposity in
RT   mice.";
RL   Nature 542:357-361(2017).
RN   [10]
RP   INTERACTION WITH DGAT2.
RX   PubMed=30970241; DOI=10.1016/j.celrep.2019.03.025;
RA   Li D., Zhao Y.G., Li D., Zhao H., Huang J., Miao G., Feng D., Liu P.,
RA   Li D., Zhang H.;
RT   "The ER-Localized Protein DFCP1 Modulates ER-Lipid Droplet Contact
RT   Formation.";
RL   Cell Rep. 27:343-358(2019).
CC   -!- FUNCTION: Mediates the ATP-dependent import of long-chain fatty acids
CC       (LCFA) into the cell by mediating their translocation at the plasma
CC       membrane (PubMed:28178239). Has also an acyl-CoA ligase activity for
CC       long-chain and very-long-chain fatty acids. May act directly as a bona
CC       fide transporter, or alternatively, in a cytoplasmic or membrane-
CC       associated multimeric protein complex to trap and draw fatty acids
CC       towards accumulation. Plays a pivotal role in regulating available LCFA
CC       substrates from exogenous sources in tissues undergoing high levels of
CC       beta-oxidation or triglyceride synthesis. May be involved in regulation
CC       of cholesterol metabolism (By similarity). Probably involved in fatty
CC       acid transport across the blood barrier (PubMed:21395585).
CC       {ECO:0000250|UniProtKB:Q60714, ECO:0000269|PubMed:21395585,
CC       ECO:0000269|PubMed:28178239}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoate(out) = (9Z)-octadecenoate(in);
CC         Xref=Rhea:RHEA:33655, ChEBI:CHEBI:30823;
CC         Evidence={ECO:0000269|PubMed:12556534, ECO:0000269|PubMed:21395585};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33656;
CC         Evidence={ECO:0000269|PubMed:12556534, ECO:0000269|PubMed:21395585};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoate(out) = hexadecanoate(in); Xref=Rhea:RHEA:45256,
CC         ChEBI:CHEBI:7896; Evidence={ECO:0000269|PubMed:12556534,
CC         ECO:0000269|PubMed:21395585};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45257;
CC         Evidence={ECO:0000269|PubMed:12556534, ECO:0000269|PubMed:21395585};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoate(out) = (9Z,12Z)-
CC         octadecadienoate(in); Xref=Rhea:RHEA:45264, ChEBI:CHEBI:30245;
CC         Evidence={ECO:0000269|PubMed:12556534};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45265;
CC         Evidence={ECO:0000269|PubMed:12556534};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a fatty acid(in) = a fatty acid(out); Xref=Rhea:RHEA:38879,
CC         ChEBI:CHEBI:28868; Evidence={ECO:0000269|PubMed:20530735};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38881;
CC         Evidence={ECO:0000269|PubMed:20530735};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + ATP + CoA =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + AMP + diphosphate;
CC         Xref=Rhea:RHEA:19713, ChEBI:CHEBI:30616, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57287, ChEBI:CHEBI:57368,
CC         ChEBI:CHEBI:456215; EC=6.2.1.15;
CC         Evidence={ECO:0000250|UniProtKB:Q60714};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19714;
CC         Evidence={ECO:0000250|UniProtKB:Q60714};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + CoA + tetracosanoate = AMP + diphosphate +
CC         tetracosanoyl-CoA; Xref=Rhea:RHEA:33639, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:31014, ChEBI:CHEBI:33019, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:65052, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000250|UniProtKB:Q60714};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33640;
CC         Evidence={ECO:0000250|UniProtKB:Q60714};
CC   -!- ACTIVITY REGULATION: Inhibited by Triacsin C.
CC       {ECO:0000250|UniProtKB:Q60714}.
CC   -!- SUBUNIT: Self-associates. May function as a homodimer (By similarity).
CC       Interacts with EPRS1; mediates the translocation of SLC27A1 from the
CC       cytoplasm to the plasma membrane thereby increasing the uptake of long-
CC       chain fatty acids (PubMed:28178239). Interacts with DGAT2 and this
CC       interaction is enhanced in the presence of ZFYVE1 (PubMed:28178239).
CC       {ECO:0000250|UniProtKB:Q60714, ECO:0000269|PubMed:28178239,
CC       ECO:0000269|PubMed:30970241}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q60714};
CC       Single-pass membrane protein {ECO:0000250|UniProtKB:Q60714}.
CC       Endomembrane system {ECO:0000250|UniProtKB:Q60714}; Single-pass
CC       membrane protein {ECO:0000250|UniProtKB:Q60714}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q60714}. Note=Plasma membrane and intracellular
CC       membranes, at least in adipocytes. In adipocytes, but not myocytes,
CC       insulin via the mTORC1 signaling pathway induces a rapid translocation
CC       of SLC27A1 from intracellular compartments to the plasma membrane,
CC       paralleled by increased LCFA uptake. Insulin-dependent translocation
CC       from the cytoplasm to the cell membrane is regulated by EPRS1.
CC       Predominantly cytoplasmic in myocytes. {ECO:0000250|UniProtKB:Q60714}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6PCB7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6PCB7-2; Sequence=VSP_055806, VSP_055807;
CC   -!- TISSUE SPECIFICITY: Highest levels of expression are detected in muscle
CC       and adipose tissue small, intermediate levels in small intestine, and
CC       barely detectable in liver. Expressed in brain gray matter
CC       (PubMed:21395585). {ECO:0000269|PubMed:10873384,
CC       ECO:0000269|PubMed:21395585}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK299852; BAH13148.1; -; mRNA.
DR   EMBL; AC010319; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010618; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84611.1; -; Genomic_DNA.
DR   EMBL; BC059399; AAH59399.1; -; mRNA.
DR   CCDS; CCDS32953.1; -. [Q6PCB7-1]
DR   RefSeq; NP_940982.1; NM_198580.2. [Q6PCB7-1]
DR   RefSeq; XP_011526305.1; XM_011528003.2. [Q6PCB7-1]
DR   BioGRID; 132009; 4.
DR   IntAct; Q6PCB7; 1.
DR   MINT; Q6PCB7; -.
DR   STRING; 9606.ENSP00000252595; -.
DR   BindingDB; Q6PCB7; -.
DR   ChEMBL; CHEMBL2052038; -.
DR   GuidetoPHARMACOLOGY; 1108; -.
DR   SwissLipids; SLP:000000427; -.
DR   TCDB; 4.C.1.1.9; the fatty acid transporter (fat) family.
DR   iPTMnet; Q6PCB7; -.
DR   PhosphoSitePlus; Q6PCB7; -.
DR   BioMuta; SLC27A1; -.
DR   DMDM; 74749156; -.
DR   EPD; Q6PCB7; -.
DR   jPOST; Q6PCB7; -.
DR   MassIVE; Q6PCB7; -.
DR   MaxQB; Q6PCB7; -.
DR   PaxDb; Q6PCB7; -.
DR   PeptideAtlas; Q6PCB7; -.
DR   PRIDE; Q6PCB7; -.
DR   ProteomicsDB; 67060; -. [Q6PCB7-1]
DR   Antibodypedia; 1644; 160 antibodies.
DR   Ensembl; ENST00000252595; ENSP00000252595; ENSG00000130304. [Q6PCB7-1]
DR   Ensembl; ENST00000598424; ENSP00000472313; ENSG00000130304. [Q6PCB7-2]
DR   GeneID; 376497; -.
DR   KEGG; hsa:376497; -.
DR   UCSC; uc002ngu.2; human. [Q6PCB7-1]
DR   CTD; 376497; -.
DR   DisGeNET; 376497; -.
DR   GeneCards; SLC27A1; -.
DR   HGNC; HGNC:10995; SLC27A1.
DR   HPA; ENSG00000130304; Low tissue specificity.
DR   MIM; 600691; gene.
DR   neXtProt; NX_Q6PCB7; -.
DR   OpenTargets; ENSG00000130304; -.
DR   PharmGKB; PA35869; -.
DR   VEuPathDB; HostDB:ENSG00000130304.16; -.
DR   eggNOG; KOG1179; Eukaryota.
DR   GeneTree; ENSGT00940000159323; -.
DR   HOGENOM; CLU_000022_46_2_1; -.
DR   InParanoid; Q6PCB7; -.
DR   OMA; PNAIYQE; -.
DR   OrthoDB; 312083at2759; -.
DR   PhylomeDB; Q6PCB7; -.
DR   TreeFam; TF313430; -.
DR   PathwayCommons; Q6PCB7; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-804914; Transport of fatty acids.
DR   BioGRID-ORCS; 376497; 9 hits in 990 CRISPR screens.
DR   ChiTaRS; SLC27A1; human.
DR   GeneWiki; SLC27A1; -.
DR   GenomeRNAi; 376497; -.
DR   Pharos; Q6PCB7; Tchem.
DR   PRO; PR:Q6PCB7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q6PCB7; protein.
DR   Bgee; ENSG00000130304; Expressed in heart left ventricle and 192 other tissues.
DR   ExpressionAtlas; Q6PCB7; baseline and differential.
DR   Genevisible; Q6PCB7; HS.
DR   GO; GO:0009925; C:basal plasma membrane; ISS:ARUK-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:ARUK-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0047676; F:arachidonate-CoA ligase activity; IEA:UniProtKB-EC.
DR   GO; GO:0015225; F:biotin transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0015562; F:efflux transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0015245; F:fatty acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0005324; F:long-chain fatty acid transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0004467; F:long-chain fatty acid-CoA ligase activity; ISS:UniProtKB.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:1901480; F:oleate transmembrane transporter activity; IEA:RHEA.
DR   GO; GO:0090434; F:oleoyl-CoA ligase activity; ISS:ARUK-UCL.
DR   GO; GO:0031957; F:very long-chain fatty acid-CoA ligase activity; IEA:Ensembl.
DR   GO; GO:0033211; P:adiponectin-activated signaling pathway; IBA:GO_Central.
DR   GO; GO:1905135; P:biotin import across plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0015878; P:biotin transport; IDA:ARUK-UCL.
DR   GO; GO:0032049; P:cardiolipin biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0140115; P:export across plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0044381; P:glucose import in response to insulin stimulus; ISS:ARUK-UCL.
DR   GO; GO:1990379; P:lipid transport across blood-brain barrier; IMP:ARUK-UCL.
DR   GO; GO:0015911; P:long-chain fatty acid import across plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0044539; P:long-chain fatty acid import into cell; IMP:UniProtKB.
DR   GO; GO:0015909; P:long-chain fatty acid transport; IDA:ARUK-UCL.
DR   GO; GO:0001579; P:medium-chain fatty acid transport; IBA:GO_Central.
DR   GO; GO:0071072; P:negative regulation of phospholipid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006655; P:phosphatidylglycerol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006659; P:phosphatidylserine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0031652; P:positive regulation of heat generation; IBA:GO_Central.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0019222; P:regulation of metabolic process; TAS:Reactome.
DR   GO; GO:0009409; P:response to cold; IBA:GO_Central.
DR   GO; GO:0032868; P:response to insulin; IBA:GO_Central.
DR   GO; GO:0150104; P:transport across blood-brain barrier; NAS:ARUK-UCL.
DR   Gene3D; 3.40.50.12780; -; 1.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; AMP-dep_Synthh-like_sf.
DR   InterPro; IPR030308; FATP1.
DR   PANTHER; PTHR43107:SF7; PTHR43107:SF7; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Fatty acid metabolism;
KW   Ligase; Lipid metabolism; Lipid transport; Membrane; Nucleotide-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..646
FT                   /note="Long-chain fatty acid transport protein 1"
FT                   /id="PRO_0000193201"
FT   TOPO_DOM        1..13
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q60714"
FT   TRANSMEM        14..34
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        35..646
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q60714"
FT   NP_BIND         246..257
FT                   /note="AMP"
FT                   /evidence="ECO:0000250|UniProtKB:Q60714"
FT   REGION          191..475
FT                   /note="Sufficient for oligomerization"
FT                   /evidence="ECO:0000250|UniProtKB:Q60714"
FT   VAR_SEQ         1..8
FT                   /note="MRAPGAGA -> MTHVLGTT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055806"
FT   VAR_SEQ         9..187
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055807"
SQ   SEQUENCE   646 AA;  71108 MW;  0E1FBA81922567E0 CRC64;
     MRAPGAGAAS VVSLALLWLL GLPWTWSAAA ALGVYVGSGG WRFLRIVCKT ARRDLFGLSV
     LIRVRLELRR HQRAGHTIPR IFQAVVQRQP ERLALVDAGT GECWTFAQLD AYSNAVANLF
     RQLGFAPGDV VAIFLEGRPE FVGLWLGLAK AGMEAALLNV NLRREPLAFC LGTSGAKALI
     FGGEMVAAVA EVSGHLGKSL IKFCSGDLGP EGILPDTHLL DPLLKEASTA PLAQIPSKGM
     DDRLFYIYTS GTTGLPKAAI VVHSRYYRMA AFGHHAYRMQ AADVLYDCLP LYHSAGNIIG
     VGQCLIYGLT VVLRKKFSAS RFWDDCIKYN CTVVQYIGEI CRYLLKQPVR EAERRHRVRL
     AVGNGLRPAI WEEFTERFGV RQIGEFYGAT ECNCSIANMD GKVGSCGFNS RILPHVYPIR
     LVKVNEDTME LLRDAQGLCI PCQAGEPGLL VGQINQQDPL RRFDGYVSES ATSKKIAHSV
     FSKGDSAYLS GDVLVMDELG YMYFRDRSGD TFRWRGENVS TTEVEGVLSR LLGQTDVAVY
     GVAVPGVEGK AGMAAVADPH SLLDPNAIYQ ELQKVLAPYA RPIFLRLLPQ VDTTGTFKIQ
     KTRLQREGFD PRQTSDRLFF LDLKQGHYLP LNEAVYTRIC SGAFAL
//
